Significant detection of new germline pathogenic variants in Australian Pancreatic Cancer Screening Program participants

Significant detection of new germline pathogenic variants in Australian Pancreatic Cancer Screening Program participants

Abstract Background The Australian Pancreatic Cancer Screening Program (APCSP) offers endoscopic ultrasound surveillance for individuals at increased risk of pancreatic ductal adenocarcinoma (PDAC) with all participants requiring assessment by a Familial Cancer Service before or after study enrolmen...

Full description

Bibliographic Details
Main Authors: Krithika Murali, Tanya M. Dwarte, Mehrdad Nikfarjam, Katherine M. Tucker, Rhys B. Vaughan, Marios Efthymiou, Allison Collins, Allan D. Spigelman, Lucinda Salmon, Amber L. Johns, David B. Williams, Martin B. Delatycki, Thomas John, Alina Stoita
Format: Article
Language:English
Published: BMC 2021-08-01
Series:Hereditary Cancer in Clinical Practice
Subjects:
Pancreatic cancer
Cancer screening
Genetics
Genetic testing
Pathogenic variant
Hereditary Cancer syndromes
Online Access:https://doi.org/10.1186/s13053-021-00190-1

Internet

https://doi.org/10.1186/s13053-021-00190-1

Similar Items